HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)
Clinical trials for HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) explained in plain language.
Never miss a new study
Get alerted when new HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) trials appear
Sign up with your email to follow new studies for HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immune booster trial targets stubborn stomach virus in transplant patients
Disease control Recruiting nowThis early-stage study tests whether giving specially trained immune cells (norovirus-specific T-cells) is safe for people with chronic norovirus infection who have weak immune systems due to stem cell or organ transplants or primary immune disorders. About 48 participants will r…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)
Phase: PHASE1 • Sponsor: Children's National Research Institute • Aim: Disease control
Last updated Jun 16, 2026 22:37 UTC
-
Decades after transplant: does excess iron harm the liver?
Knowledge-focused Recruiting nowThis study follows 500 adults who received a stem cell transplant at least 10 years ago to see if iron buildup in the body raises the risk of liver problems. Researchers will use blood tests and a special liver scan (FibroScan) to check for damage. The goal is to understand wheth…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 12, 2026 12:03 UTC